RGDXQライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (16 5月 2023 @ 01:32):

Stats
本日の出来高	77 000.00
平均出来高	0.00
時価総額	116.00
EPS	$-0.108 ( 2015-03-31 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

ボリューム相関

長: -0.48 (neutral)

短: 0.00 (neutral)

Signal:(51.968) Neutral

Response Genetics, Inc 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Response Genetics, Inc 相関 - 通貨/商品

0.00
( neutral )

Response Genetics, Inc 財務諸表

Annual	2015
収益:	$18.04M
総利益:	$3.94M (21.85 %)
EPS:	$-0.521

FY	2015
収益:	$18.04M
総利益:	$3.94M (21.85 %)
EPS:	$-0.521

FY	2014
収益:	$16.72M
総利益:	$6.71M (40.12 %)
EPS:	$-0.350

FY	2013
収益:	$19.80M
総利益:	$9.35M (47.20 %)
EPS:	$-0.240

Financial Reports:

No articles found.

Response Genetics, Inc

Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally. The company offers tests for measuring predictive factors for therapy response in tumor tissue samples. It provides testing services for non-small cell lung cancer, colorectal cancer, gastric and gastroesophageal cancer, melanoma and thyroid cancer, breast cancer, and glioma through its ResponseDX: Lung, ResponseDX: Colon, ResponseDX: Gastric, ResponseDX: Melanoma, ResponseDX: Thyroid, ResponseDX: Breast, ResponseDX: Glioma, and ResponseDX: Tissue of Origin test suites. The company also develops tests for other tumor types; and provides technical component and professional component testing services. It serves community based oncologists, pathologists, physician offices, hospitals, and pharmaceutical companies through its sales force. The company was formerly known as Bio Type, Inc. and changed its name to Response Genetics, Inc. in August 2000. Response Genetics, Inc. was founded in 1999 and is headquartered in Los Angeles, California.